查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美肠内营养市场预测至 2030 年 - 区域分析 - 按产品类型、应用、年龄层和配销通路
市场调查报告书
商品编码
1494338

北美肠内营养市场预测至 2030 年 - 区域分析 - 按产品类型、应用、年龄层和配销通路

North America Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 114 Pages | 订单完成后即时交付

价格

2022年北美肠内营养市场价值为32.0658亿美元，预计到2030年将达到51.8748亿美元；预计2022年至2030年复合年增长率为6.2%。

胃肠道疾病盛行率的增加推动了北美肠内营养市场

胃肠道疾病包括克隆氏症、肠阻塞、溃疡性结肠炎、短肠症候群、显微镜下结肠炎和某些癌症类型。根据 2019 年全球疾病负担研究，2019 年全球记录了约 490 万例发炎性肠道疾病 (IBD) 病例；美国（762,890 例）的病例数最多，盛行率分别为每 10 万人中 66.9 例和 245.3 例。克罗恩病是一种复杂的慢性疾病，主要影响消化系统。此外，每年每 100 万人中约有 3 人患有短肠症候群 (SBS)。根据 2020 年发表的题为「了解短肠症候群：现况与未来展望」的文章，SBS 的盛行率在过去 40 年中增加了两倍多。在美国，SBS 的盛行率约为每 1,000 万人中有 300 例。

患有胃肠道疾病的患者营养恶化的风险较高，因为他们被要求在接受诊断测试之前禁食。他们也可能因治疗性饮食限製而面临营养恶化，以及厌食症或营养需求改变引起的食慾不振，这可能是疾病本身造成的。因此，由于这些患者无法摄取食物，建议进行医学营养治疗。优选肠内途径来提供他们必需的营养。肠内餵食是指透过口腔或经由消化道（口腔到胃/小肠，然后肛门）的管道直接摄取食物营养物质。这种类型的营养优选为患有慢性疾病的患者提供治疗支持，例如神经系统疾病、胃肠道疾病和遗传性代谢疾病。因此，胃肠道疾病盛行率的激增推动了肠内营养市场的成长。

北美肠内营养市场概况

北美肠内营养市场分为美国、加拿大和墨西哥。由于慢性病盛行率不断上升、市场参与者不断发展的策略发展以及对肠内营养的日益偏好，北美占据了重要的市场份额，这些都促进了该地区的市场进步。此外，人们对医疗营养（例如管饲）在治疗慢性健康状况方面的益处的认识不断增加，预计将在预测期内推动北美肠内营养市场的成长。

癌症和心臟病等慢性疾病是美国残疾和死亡的主要原因。根据国家慢性病预防和健康促进中心的数据，全国十分之六的人至少患有一种慢性病。此外，美国医院协会估计约有 1.33 亿人患有至少一种慢性病，预计到 2030 年这一数字将达到 1.7 亿人。

北美肠内营养市场收入及 2030 年预测（百万美元）

北美肠内营养市场细分

北美肠内营养市场根据产品类型、应用、年龄层、配销通路和国家进行细分。

根据产品类型，北美肠内营养市场分为一般型和特定疾病型。到 2022 年，普通细分市场将占据更大的北美肠内营养市场。

在应用方面，北美肠内营养市场细分为胃肠道疾病、代谢/先天性代谢缺陷、食物过敏、肾臟疾病、肝臟疾病、肿瘤学、神经病学等。 2022 年，胃肠道疾病领域占据北美肠内营养市场最大份额。

根据年龄组，北美肠内营养市场分为成人和儿童。到 2022 年，成人细分市场将占据更大的北美肠内营养市场。

依配销通路，北美肠内营养市场分为医院药局、零售店、电子商务等。 2022 年，医院药局部门占据北美肠内营养市场最大份额。

依国家划分，北美肠内营养市场分为美国、加拿大和墨西哥。 2022年，美国主导北美肠内营养市场。

Abbott Laboratories、雀巢 SA、达能 SA、Fresenius SE & Co KGaA、B Braun SE、Dr Schar AG、Reckitt Benckiser Group Plc、 Nutritional Medicinals LLC、Kate Farms Inc、Royal FrieslandCampina NV、Arla Foods amba、Perrigo Co Plc 和 Font Co Plc -Operative Group Ltd 是北美肠内营养市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美肠内营养市场 - 主要产业动态

  • 主要市场驱动因素：
    • 胃肠道疾病盛行率增加
    • 营养不良和早产病例不断增加
  • 市场限制
    • 与肠内餵食系统相关的併发症
  • 市场机会
    • 主要市场参与者的策略性倡议
  • 未来的趋势
    • 特定配方和植物性营养产品
  • 影响分析

第 5 章：肠内营养市场 - 北美市场分析

  • 北美肠内营养市场收入，2022 - 2030

第 6 章：北美肠内营养市场 - 2030 年收入与预测 - 按产品类型

  • 概述
  • 北美肠内营养市场收入份额，按产品类型 2022 年和 2030 年 (%)
  • 一般的
  • 特定疾病

第 7 章：北美肠内营养市场 - 2030 年收入与预测 - 按应用

  • 概述
  • 2022 年及 2030 年北美肠内营养市场收入份额，依应用划分 (%)
  • 胃肠道疾病
  • 代谢/先天性代谢缺陷
  • 过敏
  • 肾臟疾病
  • 肝病
  • 肿瘤学
  • 神经病学
  • 其他的

第 8 章：北美肠内营养市场 - 收入和 2030 年预测 - 按年龄组

  • 概述
  • 北美肠内营养市场收入份额，按年龄组 2022 年和 2030 年 (%)
  • 成人
  • 儿科

第 9 章：北美肠内营养市场 - 2030 年收入和预测 - 按配销通路

  • 概述
  • 2022 年及 2030 年北美肠内营养市场收入份额，依配销通路划分 (%)
  • 医院药房
  • 零售店
  • 电子商务
  • 其他的

第 10 章：北美肠内营养市场 - 国家分析

  • 我们
  • 加拿大
  • 墨西哥

第 11 章：肠内营养市场-产业格局

  • 概述
  • 肠内营养市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • Nestle SA
  • Danone SA
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Dr Schar AG
  • Reckitt Benckiser Group Plc
  • Nutritional Medicinals LLC
  • Kate Farms Inc
  • Royal FrieslandCampina NV
  • Arla Foods amba
  • Perrigo Co Plc
  • Fonterra Co-Operative Group Ltd

第 13 章：附录

Product Code: BMIRE00029862

The North America enteral nutrition market was valued at US$ 3,206.58 million in 2022 and is expected to reach US$ 5,187.48 million by 2030; it is estimated to grow at a CAGR of 6.2% from 2022 to 2030.

Increasing Prevalence of Gastrointestinal Diseases Fuel North America Enteral Nutrition Market

Gastrointestinal diseases include Crohn's disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancer types. As per the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn's disease is a complex, chronic disorder primarily affecting the digestive system. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled "Understanding Short Bowel Syndrome: Current Status and Future Perspectives," published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence of SBS was ~300 cases per 10 million in the US.

Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Thus, medical nutrition is recommended for these patients due to their inability to ingest food. Enteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to the direct intake of food nutrients through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Therefore, the surging prevalence of gastrointestinal diseases drives the growth of the enteral nutrition market.

North America Enteral Nutrition Market Overview

The North America enteral nutrition market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions are anticipated to boost the North America enteral nutrition market growth during the forecast period.

Chronic diseases, such as cancer and heart disease, are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country have at least one chronic disease. Additionally, the American Hospital Association estimates ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.

North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

North America Enteral Nutrition Market Segmentation

The North America enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the North America enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger North America enteral nutrition market share in 2022.

In terms of application, the North America enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest North America enteral nutrition market share in 2022.

Based on age group, the North America enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger North America enteral nutrition market share in 2022.

By distribution channel, the North America enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest North America enteral nutrition market share in 2022.

Based on country, the North America enteral nutrition market is categorized into the US, Canada, and Mexico. The US dominated the North America enteral nutrition market in 2022.

Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Dr Schar AG, Reckitt Benckiser Group Plc, Nutritional Medicinals LLC, Kate Farms Inc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the North America enteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Enteral Nutrition Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Gastrointestinal Diseases
    • 4.1.2 Rising Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Complications Associated with Enteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 4.5 Impact Analysis

5. Enteral Nutrition Market - North America Market Analysis

  • 5.1 North America Enteral Nutrition Market Revenue (US$ million), 2022 - 2030

6. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 6.3 General
    • 6.3.1 Overview
    • 6.3.2 General: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 North America Enteral Nutrition Market, by General
        • 6.3.2.1.1 North America Enteral Nutrition Market, by Elemental Formula
  • 6.4 Disease Specific
    • 6.4.1 Overview
    • 6.4.2 Disease Specific: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Gastrointestinal Disorder
    • 7.3.1 Overview
    • 7.3.2 Gastrointestinal Disorder: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Metabolic/Inborn Errors of Metabolism
    • 7.4.1 Overview
    • 7.4.2 Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Allergy
    • 7.5.1 Overview
    • 7.5.2 Allergy: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Renal Disease
    • 7.6.1 Overview
    • 7.6.2 Renal Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Liver Disease
    • 7.7.1 Overview
    • 7.7.2 Liver Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Oncology
    • 7.8.1 Overview
    • 7.8.2 Oncology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Neurology
    • 7.9.1 Overview
    • 7.9.2 Neurology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group

  • 8.1 Overview
  • 8.2 North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • 8.3 Adult
    • 8.3.1 Overview
    • 8.3.2 Adult: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pediatric
    • 8.4.1 Overview
    • 8.4.2 Pediatric: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Stores
    • 9.4.1 Overview
    • 9.4.2 Retail Stores: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 E-Commerce
    • 9.5.1 Overview
    • 9.5.2 E-Commerce: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Enteral Nutrition Market - Country Analysis

  • 10.1 North America Enteral Nutrition Market, Revenue and Forecast To 2030
    • 10.1.1 North America Enteral Nutrition Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.1.3 US Enteral Nutrition Market, by Product Type
        • 10.1.1.1.3.1 US Enteral Nutrition Market, by General
        • 10.1.1.1.3.1.1 US Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.1.4 US Enteral Nutrition Market, by Application
        • 10.1.1.1.5 US Enteral Nutrition Market, by Age Group
        • 10.1.1.1.6 US Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.2.3 Canada Enteral Nutrition Market, by Product Type
        • 10.1.1.2.3.1 Canada Enteral Nutrition Market, by General
        • 10.1.1.2.3.1.1 Canada Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.2.4 Canada Enteral Nutrition Market, by Application
        • 10.1.1.2.5 Canada Enteral Nutrition Market, by Age Group
        • 10.1.1.2.6 Canada Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.3.3 Mexico Enteral Nutrition Market, by Product Type
        • 10.1.1.3.3.1 Mexico Enteral Nutrition Market, by General
        • 10.1.1.3.3.1.1 Mexico Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.3.4 Mexico Enteral Nutrition Market, by Application
        • 10.1.1.3.5 Mexico Enteral Nutrition Market, by Age Group
        • 10.1.1.3.6 Mexico Enteral Nutrition Market, by Distribution Channel

11. Enteral Nutrition Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Enteral Nutrition Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Nestle SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danone SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Fresenius SE & Co KGaA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 B Braun SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Dr Schar AG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Reckitt Benckiser Group Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Nutritional Medicinals LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Kate Farms Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Royal FrieslandCampina NV
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Arla Foods amba
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Perrigo Co Plc
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Fonterra Co-Operative Group Ltd
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Enteral Nutrition Market Segmentation
  • Table 2. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - General
  • Table 3. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 4. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 5. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 6. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 7. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 8. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 9. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 10. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 11. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 12. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 13. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 14. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 15. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 16. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 17. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 18. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 19. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 20. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 21. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 22. Recent Inorganic Growth Strategies in the Enteral Nutrition Market
  • Table 23. Recent Organic Growth Strategies in the Enteral Nutrition Market
  • Table 24. Glossary of Terms, Enteral Nutrition Market

List Of Figures

  • Figure 1. North America Enteral Nutrition Market Segmentation, By Country
  • Figure 2. North America Enteral Nutrition Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Enteral Nutrition Market Revenue (US$ million), 2020 - 2030
  • Figure 5. North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • Figure 6. General: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Disease Specific: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 9. Gastrointestinal Disorder: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Allergy: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Renal Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Liver Disease: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Neurology: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • Figure 18. Adult: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pediatric: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 21. Hospital Pharmacies: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: North America Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America Enteral Nutrition Market, 2022 (US$ million)
  • Figure 26. North America Enteral Nutrition Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 28. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 29. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 30. Growth Strategies in the Enteral Nutrition Market